Resultados de búsqueda - Agrima Mian
- Mostrando 1 - 5 Resultados de 5
-
1
Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter Analysis por Adam S. Kittai, Ying Huang, Max J. Gordon, Nathan Denlinger, Agrima Mian, Lindsey Fitzgerald, Jennifer Bishop, Sarah Nagle, Deborah M. Stephens, Samantha Jaglowski, Brian T. Hill, Alexey V. Danilov
Publicado 2020Artigo -
2
The association of D-dimers with mortality, intensive care unit admission or acute respiratory distress syndrome in patients hospitalized with coronavirus disease 2019 (COVID-19):... por Agam Bansal, Achintya D. Singh, Vardhmaan Jain, Manik Aggarwal, Samiksha Gupta, Rana Prathap Padappayil, Mahum Nadeem, Sonya Joshi, Agrima Mian, Tyler Greathouse, David A. Wells, Mohak Gupta, Muhammad Zarrar Khan
Publicado 2020Revisão -
3
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma por Geoffrey Shouse, Andy Kaempf, Max J. Gordon, Andrew Artz, David Yashar, Audrey M. Sigmund, Gordon Smilnak, Steven M. Bair, Agrima Mian, Lindsey Fitzgerald, Amneet Bajwa, Samantha Jaglowski, Neil A. Bailey, Mazyar Shadman, Krish Patel, Deborah M. Stephens, Manali Kamdar, Brian T. Hill, Jordan Gauthier, Reem Karmali, Loretta J. Nastoupil, Adam S. Kittai, Alexey V. Danilov
Publicado 2023Artigo -
4
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers por Andrew M. Evens, Alexey V. Danilov, Deepa Jagadeesh, Amy Sperling, Seo‐Hyun Kim, Ryan Vaca, Catherine Wei, Daniel Rector, Suchitra Sundaram, Nishitha Reddy, Yong Lin, Umar Farooq, Christopher R. D’Angelo, David A. Bond, Stephanie Berg, Michael C. Churnetski, Amandeep Godara, Nadia Khan, Yun Kyong Choi, Maryam Sarraf Yazdy, Emma Rabinovich, Gaurav Varma, Reem Karmali, Agrima Mian, Malvi Savani, Madelyn Burkart, Peter Martin, Albert Ren, Ayushi Chauhan, Catherine Diefenbach, Allandria Straker-Edwards, Andreas K. Klein, Kristie A. Blum, Kirsten M Boughan, Scott E. Smith, Brad M. Haverkos, Victor M. Orellana‐Noia, Vaishalee P. Kenkre, Adam Zayac, Jeremy Ramdial, Seth Maliske, Narendranath Epperla, Parameswaran Venugopal, Tatyana Feldman, Stephen D. Smith, Andrzej Stadnik, Kevin A. David, Seema Naik, Izidore S. Lossos, Matthew A. Lunning, Paolo F. Caimi, Manali Kamdar, Neil Palmisiano, Veronika Bachanová, Craig A. Portell, Tycel Phillips, Adam J. Olszewski, Juan Pablo Alderuccio
Publicado 2021Artigo -
5
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis por Juan Pablo Alderuccio, Adam J. Olszewski, Andrew M. Evens, Graham P. Collins, Alexey V. Danilov, Mark Bower, Deepa Jagadeesh, Catherine Zhu, Amy Sperling, Seo‐Hyun Kim, Ryan Vaca, Catherine Wei, Suchitra Sundaram, Nishitha Reddy, Alessia Dalla Pria, Christopher R. D’Angelo, Umar Farooq, David A. Bond, Stephanie Berg, Michael C. Churnetski, Amandeep Godara, Nadia Khan, Yun Kyong Choi, Shireen Kassam, Maryam Sarraf Yazdy, Emma Rabinovich, Frank A. Post, Gaurav Varma, Reem Karmali, Madelyn Burkart, Peter Martin, Albert Ren, Ayushi Chauhan, Catherine Diefenbach, Allandria Straker-Edwards, Andreas K. Klein, Kristie A. Blum, Kirsten M Boughan, Agrima Mian, Bradley M. Haverkos, Victor M. Orellana‐Noia, Vaishalee P. Kenkre, Adam Zayac, Seth Maliske, Narendranath Epperla, Paolo F. Caimi, Scott E. Smith, Manali Kamdar, Parameswaran Venugopal, Tatyana Feldman, Daniel Rector, Stephen D. Smith, Andrzej Stadnik, Craig A. Portell, Yong Lin, Seema Naik, Silvia Montoto, Izidore S. Lossos, Kate Cwynarski
Publicado 2021Artigo
Herramientas de búsqueda:
Materias Relacionadas
Internal medicine
Medicine
Oncology
Chemotherapy
Confidence interval
Gastroenterology
Hazard ratio
Lymphoma
Progression-free survival
Cancer
Cohort
Diffuse large B-cell lymphoma
Proportional hazards model
Rituximab
ARDS
Acute respiratory distress
Aggressive lymphoma
Antibody
Astrobiology
B cell
BCL6
Biology
CD34
Cart
Clinical endpoint
Clinical trial
Comorbidity
Coronavirus disease 2019 (COVID-19)
Cumulative incidence
Cyclophosphamide